Literature DB >> 26544115

Patient-reported outcomes as assessment tools and predictors of long-term prognosis: a 7-year follow-up study of patients with rheumatoid arthritis.

Masayo Kojima1, Toshihisa Kojima2, Sadao Suzuki1, Nobunori Takahashi2, Koji Funahashi2, Shuji Asai2, Yutaka Yoshioka2, Kenya Terabe2, Nobuyuki Asai2, Toki Takemoto2, Naoki Ishiguro2.   

Abstract

OBJECTIVE: Whether the Boolean-based American College of Rheumatology/European League Against Rheumatism (EULAR) criteria for rheumatoid arthritis (RA) including patient-reported outcome measures (PROMs) for remission are strict for use in daily clinical practice is controversial. This study aimed to clarify the differences in the remission status defined by the criteria, including and excluding PROMs, and to identify the baseline predictors of long-term prognosis using 7-year follow-up data.
METHOD: A total of 103 RA outpatients completed the baseline and 7-year follow-up questionnaire surveys. Pain visual analogue scale (VAS) of ≤ 1/10 was used as a PROM criterion for remission.
RESULTS: Only 10 patients achieved full-remission, whereas 18 met the partial-remission criteria excluding PROM at baseline. Although 70.0% of those who achieved full remission at baseline had full or partial remission status, 77.8% of those with partial remission were categorized as having no remission at 7 years. Significant baseline differences in the remission status at 7 years were observed with regard to disease duration, pain VAS, and physical function (Short Form 36 [SF-36]). Stepwise logistic regression analysis adjusted for age and sex identified disease duration and general health perception (SF-36) as independent predictors of full-remission.
CONCLUSION: Remission criteria including PROMs are stringent but important to achieve sustained remission. Early intensive treatment and efforts to improve patients' health perceptions may result in better prognosis for RA.
© 2015 Asia Pacific League of Associations for Rheumatology and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  epidemiology; outcome measure; prognostic factor

Mesh:

Year:  2015        PMID: 26544115     DOI: 10.1111/1756-185X.12789

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  10 in total

1.  Patient-reported Outcomes as Predictors of Change in Disease Activity and Disability in Early Rheumatoid Arthritis: Results from the Yorkshire Early Arthritis Register.

Authors:  Sarah Twigg; Elizabeth M A Hensor; Paul Emery; Alan Tennant; Ann W Morgan
Journal:  J Rheumatol       Date:  2017-07-01       Impact factor: 4.666

2.  A study on characteristics of rheumatoid arthritis patients achieving remission in depression with 6 months of bDMARDs treatment.

Authors:  Yusuke Miwa; Yuzo Ikari; Masahiro Hosonuma; Mika Hatano; Tomoki Hayashi; Tsuyoshi Kasama; Kenji Sanada
Journal:  Eur J Rheumatol       Date:  2018-01-22

3.  Pixel or Paper? Validation of a Mobile Technology for Collecting Patient-Reported Outcomes in Rheumatoid Arthritis.

Authors:  Oscar Massimiliano Epis; Cinzia Casu; Laura Belloli; Emanuela Schito; Davide Filippini; Marina Muscarà; Maria Giovanna Gentile; Paula Carina Perez Cagnone; Chiara Venerelli; Massimo Sonnati; Irene Schiavetti; Eleonora Bruschi
Journal:  JMIR Res Protoc       Date:  2016-11-16

4.  Predictor of the Simplified Disease Activity Index 50 (SDAI 50) at Month 3 of bDMARD Treatment in Patients with Long-Established Rheumatoid Arthritis.

Authors:  Yusuke Miwa; Mayu Saito; Hidekazu Furuya; Ryo Yanai; Tsuyoshi Kasama
Journal:  Open Rheumatol J       Date:  2017-09-30

5.  Clinical Characteristics of Rheumatoid Arthritis Patients Achieving Functional Remission after Six Months of Non-tumor Necrosis Factor Biological Disease-Modifying Antirheumatic Drugs (DMARDs) Treatment.

Authors:  Yusuke Miwa; Mayu Saito; Hidekazu Furuya; Ryo Yanai; Yuzo Ikari; Tomoki Hayashi; Tsuyoshi Kasama; Yoichi Toyoshima; Katsunori Inagaki
Journal:  Intern Med       Date:  2017-08-10       Impact factor: 1.271

Review 6.  The Use of patient Reported Outcome Measures for Rheumatoid Arthritis in Japan: A Systematic Literature Review.

Authors:  Ann Chuo Tang; Hyunchung Kim; Bruce Crawford; Taeko Ishii; Tamas Treuer
Journal:  Open Rheumatol J       Date:  2017-04-28

7.  Clinical Characteristics of Rheumatoid Arthritis Patients Achieving Functional Remission with Six Months of Biological DMARDs Treatment.

Authors:  Yusuke Miwa; Ryo Takahashi; Yuzo Ikari; Airi Maeoka; Shinichiro Nishimi; Nao Oguro; Tomoki Hayashi; Mika Hatano; Sakiko Isojima; Ryo Yanai; Tsuyoshi Kasama; Yoichi Toyoshima; Katsunori Inagaki; Kenji Sanada
Journal:  Intern Med       Date:  2017-04-15       Impact factor: 1.271

8.  Disease activity dynamics in rheumatoid arthritis: patients' self-assessment of disease activity via WebApp.

Authors:  Ulrich A Walker; Ruediger B Mueller; Veronika K Jaeger; Robert Theiler; Adrian Forster; Patrick Dufner; Fabiana Ganz; Diego Kyburz
Journal:  Rheumatology (Oxford)       Date:  2017-10-01       Impact factor: 7.580

9.  Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease.

Authors:  Fernando Rizzello; Ignazio Olivieri; Alessandro Armuzzi; Fabio Ayala; Vincenzo Bettoli; Luca Bianchi; Luca Cimino; Antonio Costanzo; Antonio Cristaudo; Salvatore D'Angelo; Marco Daperno; Anna Chiara Fostini; Mauro Galeazzi; Michele Gilio; Paolo Gionchetti; Paolo Gisondi; Ennio Lubrano; Antonio Marchesoni; Annamaria Offidani; Ambrogio Orlando; Daniela Pugliese; Carlo Salvarani; Raffaele Scarpa; Maurizio Vecchi; Giampiero Girolomoni
Journal:  Adv Ther       Date:  2018-03-07       Impact factor: 3.845

Review 10.  Patient-Reported Outcomes in Patients with Chronic Kidney Disease and Kidney Transplant-Part 1.

Authors:  Evan Tang; Aarushi Bansal; Marta Novak; Istvan Mucsi
Journal:  Front Med (Lausanne)       Date:  2018-01-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.